[
    [
        {
            "time": "",
            "original_text": "洛阳钼业：境外并购项目收到国家发改委项目备案通知书",
            "features": {
                "keywords": [
                    "洛阳钼业",
                    "境外并购",
                    "国家发改委",
                    "项目备案"
                ],
                "sentiment_score": 0.7,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "有色金属",
                    "矿业"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "洛阳钼业：境外并购项目收到国家发改委项目备案通知书",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "有色金属：MB钴价尚有下修空间 荐6股",
            "features": {
                "keywords": [
                    "有色金属",
                    "MB钴价",
                    "下修空间"
                ],
                "sentiment_score": -0.5,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "有色金属",
                    "能源金属"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "有色金属：MB钴价尚有下修空间 荐6股",
                "Correlation": 6,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 5,
                "Duration": 5,
                "Entity_Density": 4,
                "Market_Scope": 8,
                "Time_Proximity": 6,
                "Headline_Structure": 6,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "格隆汇港股聚焦(4.22)︱君实生物TAB004/JS004获美国FDA临试批准 新东方在线稳价期结束超配2237.65万股",
            "features": {
                "keywords": [
                    "君实生物",
                    "FDA临试批准",
                    "新东方在线",
                    "稳价期结束",
                    "超配股份"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药",
                    "教育"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "格隆汇港股聚焦(4.22)︱君实生物TAB004/JS004获美国FDA临试批准 新东方在线稳价期结束超配2237.65万股",
                "Correlation": 7,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 5,
                "Market_Scope": 5,
                "Time_Proximity": 9,
                "Headline_Structure": 9,
                "Source_Recency": 9
            }
        }
    ]
]